𝛼SK or SearchFull Report - D. Western Therapeutics Institute (DWTI) (4576 JP)
SUMMARY
- D. Western Therapeutics Institute, Inc. (abbreviation: DWTI, hereinafter “the Company”) is a drug discovery bio-venture spun out from Mie University, focused on developing treatments for ophthalmic diseases.
- Since its founding under the corporate philosophy of bringing “Innovative New Drugs to the World from Japan,” the DWTI Group has engaged in the research and development of drug candidates based on proprietary scientific technology derived from its research into protein kinase inhibitor development.
- The Company has already launched four products and is one of the few drug discovery ventures in Japan with a track record of commercial launches.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Full Report - D. Western Therapeutics Institute (DWTI) (4576 JP)01 May 2026
x